Market Cap: $2.57B
BI
Beam Therapeutics Inc.
BEAM
NASDAQ (NASDAQ Global Select)USD
Market Cap: $2.57B
Beam Therapeutics: Pioneering Precision Medicine with Base Editing Technology Beam Therapeutics is at the forefront of a revolutionary approach to gene editing, utilizing its proprietary base editing…
Jim Beam’s “7 Stages of Defeat” Initiative Celebrates Football Fandom Amid Disappointments In a unique marketing move that blends sports culture with brand identity, Jim Beam, the renowned bourbon pro…
Beam Distilling Co. Launches Exclusive Private Barrel Club Experience The James B. Beam Distilling Co. announces the introduction of the Beam Private Barrel Club, an innovative initiative that allows…
Innovative Horizons: The Future of Genomics and Healthcare In the evolving landscape of healthcare, Beam Therapeutics stands out as a key player in the genomic revolution, which is gaining momentum am…
Jim Beam Celebrates Community Through Sports Partnership In a momentous occasion for both the U.S. Women's National Team (USWNT) and Jim Beam®, the two entities come together to celebrate a historic s…